Updated Jul 16, 2026
Artal Participations S.a r.l. has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $270.90M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | CAVA | CAVA GROUP, INC. | S — Open-market sale | 3.00M | $90.30 | $270.90M |
| 2026-05-09 | LXRX | LEXICON PHARMACEUTICALS, INC. | M — Option exercise | 20.42M | $0.00 | |
| 2026-02-19 | LXRX | LEXICON PHARMACEUTICALS, INC. | A — Grant or award | 41.3K | $65.00 | $2.68M |
Artal Participations S.a r.l. is a corporate insider — currently tracked as Insider of CAVA GROUP, INC. (CAVA). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($270.90M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Artal Participations S.a r.l. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.